Metaxalone
From Wikipedia, the free encyclopedia
This article does not cite any references or sources. (April 2008) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
Metaxalone
|
|
Systematic (IUPAC) name | |
5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C12H15NO3 |
Mol. mass | 221.252 g/mol |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | Unknown |
Metabolism | Hepatic |
Half life | 9.2 (± 4.8) hours |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. |
C(US) |
Legal status | |
Routes | Oral |
- Not to be confused with Metolazone, a diuretic.
Metaxalone (marketed by King Pharmaceuticals under the brand name Skelaxin) is a muscle relaxant used to relax muscles and relieve pain caused by strains, sprains, and other musculoskeletal conditions. Its exact mechanism of action is not known, but it may be due to general central nervous system depression. It is considered to be a moderately strong muscle relaxant, with relatively low incidence of side effects. Skelaxin comes in an 800 mg scored tablet. It previously came in both 400 mg and 800 mg tablets. The 400 mg tablet has been discontinued. Possible side effects include nausea, vomiting, drowsiness and CNS side effects such as dizziness, headache, and irritability.
[edit] External links
- Skelaxin (manufacturer's website)